Open original FDA record ↗Recall record
- FDA identifier
- Z-0489-2025
- Company in FDA record
- Roche Diagnostics Operations, Inc.
- FDA classification date
- Nov 19, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Source facts
- Action
- Roche issued an URGENT MEDICAL DEVICE CORRECTION notice to its consignees on 10/17/2024 via UPS Ground. The notice explained the issue, clinical significance, and requested the following actions be taken: "" HCYS kits lot number 747029 expired on September 30, 2024. Ensure any inventory you have of this lot has been discarded per your local guidelines. " Follow your laboratory s standard operating procedures to determine specific clinical implications for your patients and whether retrospective review of patient results is required. " Consult with the physician or pathologist at your facility to determine specific clinical implications for your patients. " If your facility has distributed the affected product to another site, please ensure this UMDC is provided to that site." For questions: contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336
- Initiated
- 2024-10-17
- Root cause
- Under Investigation by firm
- Distribution
- US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
- Recall number
- Z-0489-2025
- Recall status
- Open, Classified
- CDRH record ID
- 210764
- FDA classified
- 2024-11-19
- Recall event number
- 95609